{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T10:33:29Z","timestamp":1768818809842,"version":"3.49.0"},"reference-count":19,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100008126","name":"Dana-Farber\/Harvard Cancer Center Specialized Program of Research Excellence in Breast Cancer","doi-asserted-by":"publisher","award":["5 P50 CA89393\u201303"],"award-info":[{"award-number":["5 P50 CA89393\u201303"]}],"id":[{"id":"10.13039\/100008126","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Learning Objectives<\/jats:title>\n                  <jats:p>Identify predictors of excessive risk perception in women with a distant history of DCIS. Explain the importance of educating women with a history of DCIS about reasonable assessments of their risk for future breast cancer.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Introduction.<\/jats:title>\n                  <jats:p>Previous research has demonstrated that many women with ductal carcinoma in situ (DCIS) overestimate their risk for future breast cancer at the time of diagnosis and soon thereafter. This study aims to evaluate risk perceptions after 5 years.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Patients and Methods.<\/jats:title>\n                  <jats:p>In a longitudinal cohort study, we mailed long-term follow-up surveys to 315 women who had previously responded to a survey 18 months after they were diagnosed with DCIS, excluding those who had experienced recurrence and those not treated at our institution. We evaluated risk perceptions with items used previously in the cohort.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results.<\/jats:title>\n                  <jats:p>One hundred ninety-three women (61%) responded. The median time since diagnosis was 5.9 years. We excluded 12 because of recurrence. Of the 181 remaining, 32% perceived at least a moderate 5-year risk for developing DCIS again, 43% perceived at least a moderate lifetime risk for developing DCIS again, 27% perceived at least a moderate 5-year risk for invasive breast cancer, 38% perceived at least a moderate lifetime risk for invasive breast cancer, and 24% perceived at least a moderate risk for DCIS spreading to other body parts. In a multivariate model, worse financial status and higher perceived risk in the previous survey were the only predictors of at least a moderate perception of risk for DCIS spreading.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion.<\/jats:title>\n                  <jats:p>Women with a history of DCIS continue to harbor inaccurate perceptions of their risk for future breast cancer events even 5 years after diagnosis.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1634\/theoncologist.2012-0376","type":"journal-article","created":{"date-parts":[[2013,4,9]],"date-time":"2013-04-09T02:11:16Z","timestamp":1365473476000},"page":"362-368","source":"Crossref","is-referenced-by-count":32,"title":["Long-Term Risk Perceptions of Women With Ductal Carcinoma In Situ"],"prefix":"10.1093","volume":"18","author":[{"given":"Kathryn J.","family":"Ruddy","sequence":"first","affiliation":[{"name":"a Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meghan E.","family":"Meyer","sequence":"additional","affiliation":[{"name":"a Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anita","family":"Giobbie-Hurder","sequence":"additional","affiliation":[{"name":"b Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen M.","family":"Emmons","sequence":"additional","affiliation":[{"name":"c Center for Community-Based Research, Dana-Farber Cancer Institute, Boston, Massachusetts, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane C.","family":"Weeks","sequence":"additional","affiliation":[{"name":"a Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric P.","family":"Winer","sequence":"additional","affiliation":[{"name":"a Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann H.","family":"Partridge","sequence":"additional","affiliation":[{"name":"a Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2013,4,8]]},"reference":[{"key":"2021122308331161000_B1","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1002\/cncr.21069","article-title":"The natural history of low-grade ductal carcinoma in situ of the breast in women treated by biopsy only revealed over 30 years of long-term follow-up","volume":"103","author":"Sanders","year":"2005","journal-title":"Cancer"},{"key":"2021122308331161000_B2","doi-asserted-by":"crossref","first-page":"5319","DOI":"10.1200\/JCO.2009.21.8560","article-title":"Local excision alone without irradiation for ductal carcinoma in situ of the breast: A trial of the Eastern Cooperative Oncology Group","volume":"27","author":"Hughes","year":"2009","journal-title":"J Clin Oncol"},{"key":"2021122308331161000_B3","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S1470-2045(10)70266-7","article-title":"Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: Long-term results from the UK\/ANZ DCIS trial","volume":"12","author":"Cuzick","year":"2011","journal-title":"Lancet Oncol"},{"key":"2021122308331161000_B4","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/cncr.27707","article-title":"Impact of race and ethnicity on features and outcome of ductal carcinoma in situ of the breast","volume":"119","author":"Bailes","year":"2013","journal-title":"Cancer"},{"key":"2021122308331161000_B5","doi-asserted-by":"crossref","first-page":"3777","DOI":"10.1245\/s10434-012-2413-4","article-title":"Biology, treatment, and outcome in very young and older women with DCIS","volume":"12","author":"Alvarado","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"2021122308331161000_B6","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1002\/(SICI)1097-0142(20000201)88:3<596::AID-CNCR16>3.0.CO;2-N","article-title":"Factors associated with local recurrence of mammographically detected ductal carcinoma in situ in patients given breast-conserving therapy","volume":"88","author":"Kestin","year":"2000","journal-title":"Cancer"},{"key":"2021122308331161000_B7","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1080\/028418600430662","article-title":"Ductal carcinoma in situ of the breast\u2014a review of diagnosis, treatment and outcome in a hospital-based Norwegian series","volume":"39","author":"Wang","year":"2000","journal-title":"Acta Oncol"},{"key":"2021122308331161000_B8","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s10549-009-0477-z","article-title":"Psychological distress and physical health in the year after diagnosis of DCIS or invasive breast cancer","volume":"120","author":"Lauzier","year":"2010","journal-title":"Breast Cancer Res Treat"},{"key":"2021122308331161000_B9","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1093\/jnci\/djn010","article-title":"Risk perceptions and psychosocial outcomes of women with ductal carcinoma in situ: Longitudinal results from a cohort study","volume":"100","author":"Partridge","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"2021122308331161000_B10","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1002\/cncr.24832","article-title":"The role of socioeconomic status in adjustment after ductal carcinoma in situ","volume":"116","author":"Moor","year":"2010","journal-title":"Cancer"},{"key":"2021122308331161000_B11","first-page":"1","volume-title":"SF-36 Physical and Mental Health Summary Scales: A User's Manual","author":"Ware","year":"1994"},{"key":"2021122308331161000_B12","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1001\/archinte.160.7.953","article-title":"Mortality among women with ductal carcinoma in situ of the breast in the population-based surveillance, epidemiology and end results program","volume":"160","author":"Ernster","year":"2000","journal-title":"Arch Intern Med"},{"key":"2021122308331161000_B13","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1093\/jnci\/djp497","article-title":"Ductal carcinoma in situ: Should the name be changed?","volume":"102","author":"Graff","year":"2010","journal-title":"J Natl Cancer Inst"},{"key":"2021122308331161000_B14","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s10549-010-1124-4","article-title":"The management of ductal intraepithelial neoplasia (DIN): Open controversies and guidelines of the Istituto Europeo di Oncologia (IEO), Milan, Italy","volume":"128","author":"Farante","year":"2011","journal-title":"Breast Cancer Res Treat"},{"key":"2021122308331161000_B15","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/ncponc0109","article-title":"Breast pathology: Rationale for adopting the ductal intraepithelial neoplasia (DIN) classification","volume":"2","author":"Tavassoli","year":"2005","journal-title":"Nat Clin Pract Oncol"},{"key":"2021122308331161000_B16","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1200\/JCO.1998.16.2.441","article-title":"Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: Findings from National Surgical Adjuvant Breast and Bowel Project B-17","volume":"16","author":"Fisher","year":"1998","journal-title":"J Clin Oncol"},{"key":"2021122308331161000_B17","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/S0140-6736(99)05036-9","article-title":"Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial","volume":"353","author":"Fisher","year":"1999","journal-title":"Lancet"},{"key":"2021122308331161000_B18","doi-asserted-by":"crossref","first-page":"275","DOI":"10.3816\/CBC.2008.n.032","article-title":"Perceptions and management approaches of physicians who care for women with ductal carcinoma in situ","volume":"8","author":"Partridge","year":"2008","journal-title":"Clin Breast Cancer"},{"key":"2021122308331161000_B19","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1093\/jnci\/87.4.286","article-title":"Effects of individualized breast cancer risk counseling: A randomized trial","volume":"87","author":"Lerman","year":"1995","journal-title":"J Natl Cancer Inst"}],"container-title":["The Oncologist"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pericles-gcp.literatumonline.com\/doi\/pdf\/10.1634\/theoncologist.2012-0376","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/pericles-gcp.literatumonline.com\/doi\/full-xml\/10.1634\/theoncologist.2012-0376","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/18\/4\/362\/41856389\/oncolo_18_4_362.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/18\/4\/362\/41856389\/oncolo_18_4_362.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,24]],"date-time":"2021-12-24T00:20:55Z","timestamp":1640305255000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/oncolo\/article\/18\/4\/362\/6398731"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,1]]},"references-count":19,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2013,4,8]]},"published-print":{"date-parts":[[2013,4,1]]}},"URL":"https:\/\/doi.org\/10.1634\/theoncologist.2012-0376","relation":{},"ISSN":["1083-7159","1549-490X"],"issn-type":[{"value":"1083-7159","type":"print"},{"value":"1549-490X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2013,4,1]]},"published":{"date-parts":[[2013,4,1]]}}}